Netherlands· NL-0f7650de40da
Trumenba suspensie voor injectie
A meningokokkus b, multikomponenten-impfstoff product containing recombinant n. meningitidis, serogroup b, stam m98250771, a05 fhbp (factor h binding protein) variant antigeen + recombinant n. meningitidis, serogroup b, stam m98250771, b01 fhbp (factor h binding protein) variant antigeen, registered in Netherlands by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RECOMBINANT N. MENINGITIDIS, SEROGROUP B, Stam M98250771, A05 fHBP (factor H Binding Protein) VARIANT ANTIGEEN + RECOMBINANT N. MENINGITIDIS, SEROGROUP B, Stam M98250771, B01 fHBP (factor H Binding Protein) VARIANT ANTIGEEN
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Netherlands (NL)
- ATC code
- J07AH09
- ATC class
- Meningokokkus B, Multikomponenten-Impfstoff
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/17/1187
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH09
Meningokokkus b, multikomponenten-impfstoff, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7fdc672-814b-4200-a98d-1adbc2459af3 GET /v1/drugs/b7fdc672-814b-4200-a98d-1adbc2459af3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/trumenba-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Meningococcus B, multicomponent vaccine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp119262",
"excipients": [
"ALUMINIUMFOSFAAT",
"HISTIDINE, (L-)",
"NATRIUMCHLORIDE",
"POLYSORBAAT 80 (E 433)",
"WATER VOOR INJECTIE"
],
"substances": [
"RECOMBINANT N. MENINGITIDIS, SEROGROUP B, Stam M98250771, A05 fHBP (factor H Binding Protein) VARIANT ANTIGEEN",
"RECOMBINANT N. MENINGITIDIS, SEROGROUP B, Stam M98250771, B01 fHBP (factor H Binding Protein) VARIANT ANTIGEEN"
],
"leaflet_url": null,
"authorised_at": "2017/05/24",
"procedure_number": "EMEA/H/C/004051",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/17/1187",
"additional_monitoring": "N"
}See everything about meningokokkus b, multikomponenten-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.